The association between sarcoidosis and lymphoma: a retrospective and multicentre study of 46 patients.
Keywords:
sarcoidosis, lymphoma, granulomaAbstract
Background: Studies on sarcoidosis-lymphoma syndrome are scarce, and the association between these diseases is poorly understood.
Aim: To analyse the features of three types of sarcoidosis-lymphoma association (SLA) according to the time of diagnosis of both diseases and to compare the features of patients who presented with sarcoidosis before lymphoma with those of patients with sarcoidosis alone (SA) in order to identify predictive factors of lymphoma development.
Design: A multicentre retrospective comparative study was conducted in two hospitals in Lyon and one hospital in Saint-Etienne, France, between 1999 and 2022.
Methods: In the SLA group, 46 patients were included and compared to 92 patients of the SA group. Demographic characteristics, medical history, clinical presentation, laboratory and imaging findings, treatments, and outcomes were collected and analysed from medical records.
Results: The age at lymphoma diagnosis was significantly higher in the group in which sarcoidosis preceded lymphoma [65.9 years when sarcoidosis preceded lymphoma vs 48.3 years when both diseases occurred simultaneously vs 44.5 years when sarcoidosis followed lymphoma, p<0.001]. Hodgkin’s lymphoma was significantly more frequent in patients from group “simultaneous diseases" (p<0.001). There were significantly more autoimmune diseases (15.2% vs 2.17% p=0.007) in the SLA group, and patients with SA presented more frequently with night sweats (45.7% vs 11.6% p<0.001).
Conclusions: No robust predictive factor of lymphoma development in patients with sarcoidosis was identified. However, it highlighted distinct clinical scenarios according to when lymphoma is diagnosed that must be taken into account by clinicians for disease management.
References
1. Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Müller-Quernheim J. Sarcoidosis. Lancet. 2014;383:1155–67. doi:10.1016/S0140-6736(13)60680-7
2. Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, et al. Diagnosis and detection of sarcoidosis: an official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;201:e26–51. doi:10.1164/rccm.202002-0251ST
3. El Jammal T, Pavic M, Gerfaud-Valentin M, Jamilloux Y, Sève P. Sarcoidosis and cancer: a complex relationship. Front Med (Lausanne). 2020;7:594118. doi:10.3389/fmed.2020.594118
4. Brincker H, Wilbek E. The incidence of malignant tumours in patients with respiratory sarcoidosis. Br J Cancer. 1974;29:247–51. PMID:4830171
5. Brincker H. The sarcoidosis-lymphoma syndrome. Br J Cancer. 1986;54:467–73. PMID:3741778
6. Cohen PR, Kurzrock R. Sarcoidosis and malignancy. Clin Dermatol. 2007;25:326–33. doi:10.1016/j.clindermatol.2007.01.015
7. Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36:1720–48. doi:10.1038/s41375-022-01620-2
8. Judson MA. Granulomatous sarcoidosis mimics. Front Med (Lausanne). 2021;8:680989. doi:10.3389/fmed.2021.680989
9. Pastré J, Bouvry D, Juvin K, et al. Sarcoidosis-like cancer-associated granulomatosis: characteristics and a case-control comparison with sarcoidosis. J Clin Med. 2021;10:1988. doi:10.3390/jcm10091988
10. Bert A, Gilbert T, Cottin V, et al. Sarcoidosis diagnosed in the elderly: a case–control study. QJM. 2021;114:238–45. doi:10.1093/qjmed/hcaa341
11. Berkmen YM. Radiologic aspects of intrathoracic sarcoidosis. Semin Roentgenol. 1985;20:356–75. PMID:3906748
12. Jeny F, Bernaudin JF, Cohen Aubart F, et al. Diagnosis issues in sarcoidosis. Respir Med Res. 2020;77:37–45. doi:10.1016/j.resmer.2019.10.006
13. Rybicki BA, Major M, Popovich J Jr, Maliank MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145:234–41. PMID:9012596
14. Papanikolaou IC, Sharma OP. The relationship between sarcoidosis and lymphoma. Eur Respir J. 2010;36:1207–19. doi:10.1183/09031936.00034010
15. Chalayer E, Bachy E, Occelli P, et al. Sarcoidosis and lymphoma: a comparative study. QJM. 2015;108:871–8. doi:10.1093/qjmed/hcv086
16. Matsuo T, Tanaka T, Omote R, Okada T, Notohara K, Okada K. Diffuse large B-cell lymphoma in the course of systemic sarcoidosis: a case report and review of 30 Japanese patients with sarcoidosis-lymphoma syndrome. J Clin Exp Hematop. 2022;62:226–37. doi:10.3960/jslrt.22010
17. Ekström Smedby K, Vajdic CM, Falster M, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood. 2008;111:4029–38. doi:10.1182/blood-2007-10-119974
18. Smedby KE, Hjalgrim H, Askling J, et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst. 2006;98:51–60. PMID:16391371
19. Søgaard KK, Sværke C, Thomsen RW, Nørgaard M. Sarcoidosis and subsequent cancer risk: a Danish nationwide cohort study. Eur Respir J. 2015;45:269–72. doi:10.1183/09031936.00034414
20. Moreno-Torres V, Martínez-Urbistondo M, Durán-del Campo P, et al. Sarcoidosis and lymphoma mortality risk: an observational study from the Spanish National Registry. J Transl Autoimmun. 2024;8:100236. doi:10.1016/j.jtauto.2024.100236
21. Ando M, Goto A, Takeno Y, et al. Significant elevation of the levels of B-cell activating factor (BAFF) in patients with sarcoidosis. Clin Rheumatol. 2018;37:2833–8. doi:10.1007/s10067-018-4185-3
22. Mariette X. How does BAFF activate B cells in patients with autoimmune diseases? Arthritis Res Ther. 2012;14:106. PMID:22397365
23. Zintzaras E. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med. 2005;165:2337–44. doi:10.1001/archinte.165.20.2337
24. London J, Grados A, Fermé C, et al. Sarcoidosis occurring after lymphoma: report of 14 patients and review of the literature. Medicine (Baltimore). 2014;93:e121. doi:10.1097/MD.0000000000000121
25. Kadin ME, Glatstein E, Dorfman RF. Clinicopathologic studies of 117 untreated patients subjected to laparotomy for the staging of Hodgkin’s disease. Cancer. 1971;27:1277–94. PMID:5103901
26. Kim H, Dorfman RF. Morphological studies of 84 untreated patients subjected to laparotomy for the staging of non-Hodgkin’s lymphomas. Cancer. 1974;33:657–74. PMID:4811986
27. de Charry F, Sadoune K, Sebban C, et al. Association lymphome et granulomatose: à propos d’une série de cas. Rev Med Interne. 2016;37:453–9. doi:10.1016/j.revmed.2015.12.010
28. Cerri S, Fontana M, Balduzzi S, et al. Clinical differences in sarcoidosis patients with and without lymphoma: a single-centre retrospective cohort analysis. Eur Respir J. 2019;54:1802470. doi:10.1183/13993003.02470-2018
29. Alzghoul BN, Zayed Y, Obeidat A, et al. Clinical characteristics of sarcoidosis patients with self-reported lymphoma: a US nationwide registry study. Lung. 2021;199:611–8. doi:10.1007/s00408-021-00462-3
30. Amaya-Uribe L, Rojas M, Azizi G, Anaya JM, Gershwin ME. Primary immunodeficiency and autoimmunity: a comprehensive review. J Autoimmun. 2019;99:52–72. doi:10.1016/j.jaut.2019.01.011
31. Brune MM, Juskevicius D, Haslbauer J, Dirnhofer S, Tzankov A. Genomic landscape of Hodgkin lymphoma. Cancers (Basel). 2021;13:682. doi:10.3390/cancers13040682
Downloads
How to Cite
Issue
Section
License
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
